Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
3.800
+0.100 (2.70%)
Sep 4, 2026, 7:20 AM EDT - Market open
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $5.1 million as of September 4, 2026. Its market cap has decreased by -92.76% in one year.
Market Cap
5.10M
Enterprise Value
3.53M
1-Year Change
-92.76%
Ranking
Category
Stock Price
$3.80
ChartMarket Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $5.10M, a decrease of -98.52%. That is a compound annual growth rate of -55.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 5.16M | -68.76% |
| Dec 31, 2025 | 16.51M | -79.39% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
| May 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Can-Fite BioPharma | 5.73M |
| Cardio Diagnostics Holdings | 5.62M |
| Kairos Pharma | 5.45M |
| Dermata Therapeutics | 5.27M |
| PharmaCyte Biotech | 5.26M |
| Pulmatrix | 5.23M |
| GRI Bio | 4.90M |
| Cadrenal Therapeutics | 4.82M |